315 related articles for article (PubMed ID: 33295153)
21. A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer.
Wong KH; Kuciejewska A; Sharabiani MTA; Ng-Cheng-Hin B; Hoy S; Hurley T; Rydon J; Grove L; Santos A; Ryugenji M; Bhide SA; Nutting CM; Harrington KJ; Newbold KL
Radiother Oncol; 2017 Feb; 122(2):207-211. PubMed ID: 27393218
[TBL] [Abstract][Full Text] [Related]
22. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
23. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
[TBL] [Abstract][Full Text] [Related]
24. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
[TBL] [Abstract][Full Text] [Related]
27. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
29. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
30. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
31. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol.
Morais MO; Martins AFL; de Jesus APG; de Sousa Neto SS; da Costa AWF; Pereira CH; Oton-Leite AF; de Freitas NMA; Leles CR; Mendonça EF
Support Care Cancer; 2020 Sep; 28(9):4263-4273. PubMed ID: 31900618
[TBL] [Abstract][Full Text] [Related]
32. Radiation-induced Oral Mucositis in Brazilian Patients: Prevalence and Associated Factors.
Pereira IF; Firmino RT; Meira HC; DO Egito Vasconcelos BC; DE Souza Noronha VRA; Santos VR
In Vivo; 2019; 33(2):605-609. PubMed ID: 30804148
[TBL] [Abstract][Full Text] [Related]
33. Sumac-rose water mouthwash versus benzydamine to prevent radiation-induced oral mucositis in head and neck cancers: a phase II randomized trial.
Ameri A; Heydarirad G; Choopani R; Poshtmahi S; Ameri P; Talebi F; Bagheri Pour A; Taghizadeh-Hesary F
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7427-7439. PubMed ID: 36947237
[TBL] [Abstract][Full Text] [Related]
34. Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study).
Mañas A; Palacios A; Contreras J; Sánchez-Magro I; Blanco P; Fernández-Pérez C
Clin Transl Oncol; 2009 Oct; 11(10):669-76. PubMed ID: 19828409
[TBL] [Abstract][Full Text] [Related]
35. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).
Bjarnason GA; Mackenzie RG; Nabid A; Hodson ID; El-Sayed S; Grimard L; Brundage M; Wright J; Hay J; Ganguly P; Leong C; Wilson J; Jordan RC; Walker M; Tu D; Parulekar W;
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):166-72. PubMed ID: 18805649
[TBL] [Abstract][Full Text] [Related]
36. Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment.
Chen SC; Lai YH; Huang BS; Lin CY; Fan KH; Chang JT
Eur J Oncol Nurs; 2015 Jun; 19(3):214-9. PubMed ID: 25586214
[TBL] [Abstract][Full Text] [Related]
37. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
38. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus.
Morais-Faria K; Palmier NR; de Lima Correia J; de Castro Júnior G; Dias RB; da Graça Pinto H; Lopes MA; Ribeiro ACP; Brandão TB; Santos-Silva AR
Support Care Cancer; 2020 Sep; 28(9):4345-4352. PubMed ID: 31912359
[TBL] [Abstract][Full Text] [Related]
39. RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Małecka-Massalska T
Cancer Biomark; 2018; 22(4):657-667. PubMed ID: 29865035
[TBL] [Abstract][Full Text] [Related]
40. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis.
Li P; Du CR; Xu WC; Shi ZL; Zhang Q; Li ZB; Fu S
Radiat Oncol; 2013 Jun; 8():155. PubMed ID: 23803252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
